FDA Issues Class II Blood Pressure Medication Recall, Over 13,000 Bottles Affected

The FDA initiated a second recall of its 25 mg chlorthalidone tablets this year, bringing the total to more than 25,000 bottles. Anastasiia Sienotova/Getty Images 13,567 bottles of 25 mg chlorthalidone tablets were recalled after failing lab tests, according to the FDA. It’s the manufacturer’s second recall of the tablets this year, all with the same expiration date. Together, the two Class II recalls cover 25,027 bottles, according to FDA enforcement reports. Some people taking a common blood pressure medication may have pills that don’t dissolve the way they should.More than 13,500 bottles of 25 mg chlorthalidone tablets are under a nationwide recall after failing lab tests, according to the Food and Drug Administration (FDA).Inventia Healthcare Limited voluntarily recalled the tablets on September 3, 2026, according to the FDA’s enforcement report. The report lists the reason for the recall as “Failed Dissolution Specifications.” That means the tablets failed a test that measures how the medicine is released from the pill, according to the FDA.“Chlorthalidone is a diuretic, or ‘water pill,’ commonly used to treat high blood pressure and reduce excess fluid retention in the body…

≈